Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | MPI | P34949 | 1/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.35 |
| ▸ | ATM | Q13315 | 2/20 | 0.35 |
| ▸ | HTR6 | P50406 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CASP1 | P29466 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | TSPO | P30536 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24903066 | 1.00 | CYP11B1 (0.37) | CYP11B1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL24173657 | 0.97 | KDM4E (0.35) | CYP11B1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL24902544 | 0.97 | KDM4E (0.35) | CYP11B1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL23008705 | 0.96 | KDM4E (0.36) | CYP11B1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL23078065 | 0.95 | TSPO (0.36) | CYP11B1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL23078489 | 0.95 | TSPO (0.38) | CYP11B1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL23078488 | 0.95 | CYP11B1 (0.34) | CYP11B1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL24902666 | 0.95 | CYP11B1 (0.34) | CYP11B1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL23078064 | 0.95 | CYP11B1 (0.34) | CYP11B1ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL24902725 | 0.95 | CYP11B1 (0.35) | CYP11B1ALDH1A1KDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230006161-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-01-05 | — | — | US | disclosed |
| US-20210399234-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2021-12-23 | — | — | US | disclosed |
| US-10573824-B2 | Compound and organic electronic element comprising same | LG CHEM, LTD. (KR) | 2020-02-25 | — | — | US | disclosed |
| WO-2019143151-A1 | ORGANIC LIGHT-EMITTING DIODE | 주식회사 엘지화학 | 2019-07-25 | — | — | WO | disclosed |
| US-20180090688-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-03-29 | — | — | US | disclosed |
| US-20180090688-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180090688-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | OR10J3, ETV6, BMI1 | CYP11B1 2053/4885ALDH1A1 1193/4885KDM4E 390/4885 |
| US-10573824-B2 | Compound and organic electronic element comprising same | OR10J3, ETV6, BMI1 | CYP11B1 2053/4885ALDH1A1 1193/4885KDM4E 390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.